Showing 651-660 of 20873 results for "".
- Chronic Steroid Use Could Raise Diabetes Riskhttps://reachmd.com/news/chronic-steroid-use-could-raise-diabetes-risk/2468139/by Dennis Thompson Taking steroids more than doubles a person's risk of
- Bridging the Gap: Managing Cardiovascular Risk in Women with Hypertensive Pregnancy Disorders and Gestational Diabeteshttps://reachmd.com/news/cardiovascular-risks-management-in-women-with-hypertensive-disorders-of-pregnancy-and-gestational-diabetes/2474214/New research is reinforcing what clinicians have long suspected. Pregnancy complications like hypertensive disorders and gestational diabetes are more than transient concerns—they’re early harbingers of long-term cardiovascular disease. Women who experience these c
- Older Adults with Diabetes Faced Elevated Risk of Depression During the COVID-19 Pandemichttps://reachmd.com/news/older-adults-with-diabetes-faced-elevated-risk-of-depression-during-the-covid-19-pandemic/2467643/A recent study of more than 2,700 older Canadians reported older adults with diabetes faced a heightened risk of depression during the COVID-19 pandemic. In this cohort, almost 50% of those who had a pre-pandemic history of depression experienced
- Op-Ed: Confessions of a 31 Year-Old Doctor with 1 Million in Debthttps://reachmd.com/news/op-ed-confessions-of-a-31-year-old-doctor-with-1-million-in-debt/2457401/To understand how I accrued $1 million in debt, you must first understand where I come from.
- Therapeutic Plasma Exchange and Biological Aging: A New Hope in Geriatricshttps://reachmd.com/news/therapeutic-plasma-exchange-and-biological-aging-a-new-hope-in-geriatrics/2474990/Clinicians have long sought interventions capable of reversing biological aging and improving patient resilience, and now a
- Barriers To SGLT2 Inhibitor Access In Heart Failure Care In Jordanhttps://reachmd.com/news/barriers-to-sglt2-inhibitor-access-in-heart-failure-care-in-jordan/2486587/Key Takeaways: Low initiation and low reported approval for heart failure without diabetes were observed despite generally favorable physician knowledge and attitudes toward SGLT2 inhibitors. Misclassification of SGLT2 inhibitors as diabetes-only medic
- Bridging ADHD and Metabolic Disorders: Clinical Implications of Shared Pathwayshttps://reachmd.com/news/bridging-adhd-and-metabolic-disorders-clinical-implications-of-shared-pathways/2474583/Exploring the critical connection between ADHD and metabolic disorders reveals insights into dopamine gene modifications, challenges in glycemic regulation, and the effects of maternal diabetes on children. Insights from Diabetes and Endocrinolo
- Advancing Detection: Maternal A1c as a Diagnostic Tool in Early GDM Identificationhttps://reachmd.com/news/advancing-detection-maternal-a1c-as-a-diagnostic-tool-in-early-gdm-identification/2473840/The pursuit of earlier, more effective screening strategies for gestational diabetes mellitus (GDM) has led to growing interest in a nontraditional yet accessible biomarker: maternal hemoglobin A1c (HbA1c). While traditionally reserved for diabetes monitoring outsi
- UACR And UPCR In CKD Trials: Kidney Failure Riskhttps://reachmd.com/news/uacr-upcr-ckd-trials-kidney-failure-risk/2486897/Key Takeaways UACR AND UPCR were strongly associated with kidney failure, with UACR showing the stronger pooled association. The difference was clearest in type 2 diabetes and CKD and less clear in glomerular disease. In a
- GLP-1 Receptor Agonists: Bridging Metabolic Control and Cardiovascular Protectionhttps://reachmd.com/news/glp-1-receptor-agonists-bridging-metabolic-control-and-cardiovascular-protection/2475771/The expanding use of GLP-1 receptor agonists such as Ozempic is challenging the traditional divide between metabolic control and cardiovascular protection, unveiling underrecognized potential for stroke prevention in patients with type 2 diabetes. The utilization of